Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2025 09:00 ET | Source: ONCOVITA

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma Paris, France, June 4th, 2025. Oncovita, a biotechnology...
October 09, 2024 10:30 ET | Source: ONCOVITA

Oncovita appoints Stéphane Altaba as Chief Executive Officer

Paris, France, October 9th, 2024 - Oncovita, a biotechnology company specializing in the development of therapeutic cancer vaccines and prophylactic vaccines, today announced the appointment of Dr....
May 29, 2024 09:00 ET | Source: ONCOVITA

Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology

Oncovita and Institut Pasteur announce the creation of a joint laboratory dedicated to cancer immunotherapy and prophylactic vaccinology Paris, 29 May 2024 - Dedicated to the research of...